First Round Capital

Collate creates and streamlines documentation for drug development, medical device, and diagnostic companies from concept to market using artificial intelligence. They produce accurate documentation for the life sciences industry, which speeds up innovations that can save lives.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Founded in 2021, Koala Health simplifies pet care by providing medications and health products through its digital platform. It offers features such as prescription management, date-and-time-based packaging, and free delivery.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Source is a digital healthcare delivery platform founded in 2021 and headquartered in New York, United States. The company provides an operating system that enables care delivery organizations to connect with patients, coordinate care, schedule visits, and capture essential data. By facilitating collaboration among product leaders, engineers, and clinicians, Source aims to enhance healthcare experiences with a patient-centered approach. Its enterprise system is designed to support healthcare providers of all sizes in improving their virtual care capabilities.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Rupa Health operates an online platform that facilitates access to alternative healthcare providers and streamlines the process of ordering lab tests. Founded in 2018 and based in San Francisco, the company offers a comprehensive service that enables doctors to order specialty lab work, manage samples, and receive results efficiently. The platform integrates seamlessly with various lab companies, allowing healthcare professionals to order multiple tests in one place without requiring membership or subscription fees. Rupa Health also provides flexible payment options and robust support for both practitioners and patients, ensuring an efficient lab experience. The company's services include shipping test reports directly to patients' homes, simplifying the management and tracking of lab results to enhance patient care.

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Rupa Health operates an online platform that facilitates access to alternative healthcare providers and streamlines the process of ordering lab tests. Founded in 2018 and based in San Francisco, the company offers a comprehensive service that enables doctors to order specialty lab work, manage samples, and receive results efficiently. The platform integrates seamlessly with various lab companies, allowing healthcare professionals to order multiple tests in one place without requiring membership or subscription fees. Rupa Health also provides flexible payment options and robust support for both practitioners and patients, ensuring an efficient lab experience. The company's services include shipping test reports directly to patients' homes, simplifying the management and tracking of lab results to enhance patient care.

Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

Sitka is a healthcare technology company that develops a telehealth and video platform to connect patients with clinicians across specialties. The platform enables primary care providers to access a virtual specialty network and supports collaboration among endocrinology, neurology, orthopedics, pulmonology, rheumatology, and related fields. It also offers personalized, one-on-one consultation on imaging results, such as MRI, with board-certified musculoskeletal doctors to inform care decisions. The company aims to streamline the care cycle, upskill primary care, and improve patient outcomes through accessible, expert guidance. Sitka originated in San Francisco in 2018.

DNAnexus, Inc. is a cloud-based provider of genome informatics and data management tools, primarily serving enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and the integration of genomic data with clinical information. Its suite of products includes MOSAIC Microbiome for collaborative research on the human microbiome, DNAnexus Apollo for clinico-genomic data exploration, and DNAnexus Titan for data analysis. Additionally, the DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration, while the Clinico-Genomic Data Solution addresses the need for disease-specific datasets through partnerships with healthcare providers. The company has established itself as a key player in the biopharmaceutical, diagnostic, and academic research sectors, enabling clients to tackle complex challenges in human health with enhanced security and scalability. DNAnexus also maintains a strategic alliance with WuXi NextCODE Genomics and has locations in San Francisco, London, and Prague.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Cricket Health Inc. is a specialty kidney care provider that focuses on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, the company employs a technology-enabled, multidisciplinary approach to patient care, offering both in-person and virtual services. Cricket Health aims to enhance patient outcomes while providing value to healthcare partners by prioritizing patient health, reducing hospitalizations, facilitating access to transplants, and promoting home dialysis adoption. The company is dedicated to identifying at-risk patients early, managing disease progression, and delivering personalized care options such as transplant support and various dialysis modalities.

Gregor Diagnostics Inc. is a molecular diagnostics company dedicated to developing innovative screening tests for prostate cancer. Founded in 2016 and headquartered in Madison, Wisconsin, the company has created a technology that utilizes seminal fluid as a sample source. This advanced testing method enables the early detection of prostate cancer and helps differentiate between indolent and aggressive forms of the disease. By providing a reliable assessment of cancer aggressiveness, Gregor Diagnostics aims to assist physicians in reducing the risks of overdiagnosis and overtreatment of less severe cases while enhancing the management of more aggressive prostate cancer.

2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

SchoolCare is a digital health platform that provides free health technology to K-12 public schools, enabling school nurses to deliver effective care and enhance student safety. The company aims to create a unified health record for every family by leveraging pediatric health data within the extensive K-12 school system, which serves as a vital public health infrastructure. SchoolCare's platform captures essential student medical information, including charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. By addressing gaps in traditional care coordination, SchoolCare ensures that crucial care instructions reach school nurses, thereby reducing the risk of inconsistent post-discharge care. Through its innovative approach, SchoolCare seeks to improve health outcomes for children and streamline public school health programs across the United States.

Cricket Health Inc. is a specialty kidney care provider that focuses on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, the company employs a technology-enabled, multidisciplinary approach to patient care, offering both in-person and virtual services. Cricket Health aims to enhance patient outcomes while providing value to healthcare partners by prioritizing patient health, reducing hospitalizations, facilitating access to transplants, and promoting home dialysis adoption. The company is dedicated to identifying at-risk patients early, managing disease progression, and delivering personalized care options such as transplant support and various dialysis modalities.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Sano is focused on developing a small, wearable sensor capable of continuously capturing and transmitting blood chemistry data to various devices. The company is creating a transdermal biosensor patch that measures interstitial fluid in the skin's outer layer, enabling continuous glucose monitoring. This technology is complemented by a mobile application that empowers users to make informed decisions regarding their diet and exercise. By liberating blood chemistry data to a third-party development and analytical platform, Sano aims to enhance individual health management and promote healthier lifestyle choices.

Cricket Health Inc. is a specialty kidney care provider that focuses on delivering integrated nephrology and dialysis services for individuals with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Founded in 2015 and based in San Francisco, the company employs a technology-enabled, multidisciplinary approach to patient care, offering both in-person and virtual services. Cricket Health aims to enhance patient outcomes while providing value to healthcare partners by prioritizing patient health, reducing hospitalizations, facilitating access to transplants, and promoting home dialysis adoption. The company is dedicated to identifying at-risk patients early, managing disease progression, and delivering personalized care options such as transplant support and various dialysis modalities.

NeuroVigil develops non-invasive brain monitoring technology, notably the iBrain device. This platform enables remote, non-invasive tracking of various neuropathologies like Alzheimer's, autism, and epilepsy. It also facilitates drug response monitoring in clinical trials.

SchoolCare is a digital health platform that provides free health technology to K-12 public schools, enabling school nurses to deliver effective care and enhance student safety. The company aims to create a unified health record for every family by leveraging pediatric health data within the extensive K-12 school system, which serves as a vital public health infrastructure. SchoolCare's platform captures essential student medical information, including charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. By addressing gaps in traditional care coordination, SchoolCare ensures that crucial care instructions reach school nurses, thereby reducing the risk of inconsistent post-discharge care. Through its innovative approach, SchoolCare seeks to improve health outcomes for children and streamline public school health programs across the United States.

Flatiron Health, Inc. is a healthcare technology company dedicated to enhancing cancer research and patient care through advanced data integration and analytics. The firm develops OncologyCloud, a comprehensive platform that consolidates disparate healthcare information systems to provide insights into patient populations. This platform enables cancer care providers and life sciences companies to analyze treatment patterns, monitor adherence to clinical guidelines, and facilitate real-time patient matching to clinical trials. Additionally, Flatiron offers OncoCloud, a software solution for community oncology practices, and tools like Flatiron Assist and OncoEMR, which support clinical decision-making and compliance with oncology care models. Established in 2012 and headquartered in New York, Flatiron Health collaborates with over 280 community cancer practices, prominent academic research centers, and leading oncology companies, positioning itself as a key player in the oncology data landscape. The company operates as a subsidiary of Roche Holding AG.

DNAnexus, Inc. is a cloud-based provider of genome informatics and data management tools, primarily serving enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and the integration of genomic data with clinical information. Its suite of products includes MOSAIC Microbiome for collaborative research on the human microbiome, DNAnexus Apollo for clinico-genomic data exploration, and DNAnexus Titan for data analysis. Additionally, the DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration, while the Clinico-Genomic Data Solution addresses the need for disease-specific datasets through partnerships with healthcare providers. The company has established itself as a key player in the biopharmaceutical, diagnostic, and academic research sectors, enabling clients to tackle complex challenges in human health with enhanced security and scalability. DNAnexus also maintains a strategic alliance with WuXi NextCODE Genomics and has locations in San Francisco, London, and Prague.

Flatiron Health, Inc. is a healthcare technology company dedicated to enhancing cancer research and patient care through advanced data integration and analytics. The firm develops OncologyCloud, a comprehensive platform that consolidates disparate healthcare information systems to provide insights into patient populations. This platform enables cancer care providers and life sciences companies to analyze treatment patterns, monitor adherence to clinical guidelines, and facilitate real-time patient matching to clinical trials. Additionally, Flatiron offers OncoCloud, a software solution for community oncology practices, and tools like Flatiron Assist and OncoEMR, which support clinical decision-making and compliance with oncology care models. Established in 2012 and headquartered in New York, Flatiron Health collaborates with over 280 community cancer practices, prominent academic research centers, and leading oncology companies, positioning itself as a key player in the oncology data landscape. The company operates as a subsidiary of Roche Holding AG.

Sano is focused on developing a small, wearable sensor capable of continuously capturing and transmitting blood chemistry data to various devices. The company is creating a transdermal biosensor patch that measures interstitial fluid in the skin's outer layer, enabling continuous glucose monitoring. This technology is complemented by a mobile application that empowers users to make informed decisions regarding their diet and exercise. By liberating blood chemistry data to a third-party development and analytical platform, Sano aims to enhance individual health management and promote healthier lifestyle choices.

Mango Health, established in 2011 and headquartered in San Francisco, specializes in developing mobile healthcare applications. It offers a patient engagement platform that provides medication information, refill reminders, and peer comparison features to users via mobile and web-based apps. As of October 2019, Mango Health operates as a subsidiary of TrialCard Incorporated. The company partners with payers, pharmacy benefits managers, and pharmaceutical manufacturers to enhance patient engagement, reduce costs, and improve health outcomes for patients with chronic conditions. Its app has received positive user feedback, with an average rating of 4.5 stars, and has been recognized by prominent media outlets such as Apple, Google CNN, the New York Times, and Self Magazine.

Mango Health, established in 2011 and headquartered in San Francisco, specializes in developing mobile healthcare applications. It offers a patient engagement platform that provides medication information, refill reminders, and peer comparison features to users via mobile and web-based apps. As of October 2019, Mango Health operates as a subsidiary of TrialCard Incorporated. The company partners with payers, pharmacy benefits managers, and pharmaceutical manufacturers to enhance patient engagement, reduce costs, and improve health outcomes for patients with chronic conditions. Its app has received positive user feedback, with an average rating of 4.5 stars, and has been recognized by prominent media outlets such as Apple, Google CNN, the New York Times, and Self Magazine.

Truveris is a health information technology company based in New York that focuses on bringing transparency to the prescription drug ecosystem. Founded in 2009, Truveris develops management tools for sponsors and payers of claims under prescription benefit plans. Its platform offers data-driven insights to help customers, including patients, employers, retailers, pharmacy benefits stakeholders, and manufacturers, manage rising costs and market access challenges effectively. The company's solutions include RxChoice, TruBid, and RxDash, which serve various entities in the pharmacy value chain.

DNAnexus, Inc. is a cloud-based provider of genome informatics and data management tools, primarily serving enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and the integration of genomic data with clinical information. Its suite of products includes MOSAIC Microbiome for collaborative research on the human microbiome, DNAnexus Apollo for clinico-genomic data exploration, and DNAnexus Titan for data analysis. Additionally, the DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration, while the Clinico-Genomic Data Solution addresses the need for disease-specific datasets through partnerships with healthcare providers. The company has established itself as a key player in the biopharmaceutical, diagnostic, and academic research sectors, enabling clients to tackle complex challenges in human health with enhanced security and scalability. DNAnexus also maintains a strategic alliance with WuXi NextCODE Genomics and has locations in San Francisco, London, and Prague.

SchoolCare is a digital health platform that provides free health technology to K-12 public schools, enabling school nurses to deliver effective care and enhance student safety. The company aims to create a unified health record for every family by leveraging pediatric health data within the extensive K-12 school system, which serves as a vital public health infrastructure. SchoolCare's platform captures essential student medical information, including charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. By addressing gaps in traditional care coordination, SchoolCare ensures that crucial care instructions reach school nurses, thereby reducing the risk of inconsistent post-discharge care. Through its innovative approach, SchoolCare seeks to improve health outcomes for children and streamline public school health programs across the United States.

Medico.com is a global health-focused internet company that operates an online health portal designed to provide users with access to relevant health information. Initially targeting users in Spain, the platform plans to expand into other Hispanic markets, including the United States, as well as explore opportunities in diverse languages and regions, such as India. The portal features a comprehensive collection of high-quality health reference materials in Spanish, encompassing over 4,000 articles on various diseases and conditions, along with continuously updated health news. Medico.com also includes community-oriented features and a question-and-answer platform that enables users to exchange information, share personal experiences related to medical conditions, and actively engage in their health management. The services offered by Medico.com are free for users, fostering an inclusive environment for health education and support.

Truveris is a health information technology company based in New York that focuses on bringing transparency to the prescription drug ecosystem. Founded in 2009, Truveris develops management tools for sponsors and payers of claims under prescription benefit plans. Its platform offers data-driven insights to help customers, including patients, employers, retailers, pharmacy benefits stakeholders, and manufacturers, manage rising costs and market access challenges effectively. The company's solutions include RxChoice, TruBid, and RxDash, which serve various entities in the pharmacy value chain.

DNAnexus, Inc. is a cloud-based provider of genome informatics and data management tools, primarily serving enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and the integration of genomic data with clinical information. Its suite of products includes MOSAIC Microbiome for collaborative research on the human microbiome, DNAnexus Apollo for clinico-genomic data exploration, and DNAnexus Titan for data analysis. Additionally, the DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration, while the Clinico-Genomic Data Solution addresses the need for disease-specific datasets through partnerships with healthcare providers. The company has established itself as a key player in the biopharmaceutical, diagnostic, and academic research sectors, enabling clients to tackle complex challenges in human health with enhanced security and scalability. DNAnexus also maintains a strategic alliance with WuXi NextCODE Genomics and has locations in San Francisco, London, and Prague.